Advanced peptide nanomedicines for bladder cancer theranostics

HIGHLIGHTS

• who: Bladder Cancer Theranostics and colleagues from the Department of Urology, Tianjin First Central Hospital, Tianjin, China, Department of Urology, Qingdao Hospital of Traditional China, Department of Urology, First Central Clinical College, Tianjin Medical University, Tianjin, China, School of Medicine have published the paper: Advanced Peptide Nanomedicines for Bladder Cancer Theranostics, in the Journal: (JOURNAL)
• what: The aim of drug delivery is to send enough drug payloads to the lesion sites while minimizing their exposure to healthy tissues. The main reason is that the cellular internalization levels of SPIO are limited, and less than 1 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.